Startups

Neobe Therapeutics

engineered bacteria that open up solid tumours

Website ·

From our list Five new European startups to know (6 to 17 November 2026)

Neobe Therapeutics is a UK biotech company, with its lab at the Stevenage Bioscience Catalyst and a registered office in Cambridge. It engineers harmless strains of bacteria that settle inside solid tumours and break down the dense tissue around them, so that immunotherapies and immune cells can reach the cancer. The work is still preclinical. Founded in 2021 by Pedro Correa de Sampaio and Annelise Soulier, Neobe announced on 10 November 2026 a seed round of 6.8 million dollars (5 million pounds) led by ARC Ventures, bringing its total funding to more than 10.5 million dollars.

Website: neobetherapeutics.com. Source: Inside Precision Medicine.

Questions about Neobe Therapeutics

What does Neobe Therapeutics do?

Neobe Therapeutics: engineered bacteria that open up solid tumours.

Where can I read more about Neobe Therapeutics?

Neobe Therapeutics is in our list Five new European startups to know (6 to 17 November 2026): https://meetnewbrands.com/articles/five-new-european-startups-to-know-6-17-november-2026

Is this your startup?Get a free founder story written with you, or add your latest funding round. Something out of date? Tell us.Pitch your story